There are currently 603 clinical trials in Omaha, Nebraska looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Nebraska Medical Center, Creighton University Medical Center, Nebraska Methodist Hospital and Alegent Health Bergan Mercy Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
A Cross-sectional Partnership to Improve Prevention
Recruiting
This study is a non-randomized, 2-arm clinical trial comparing the effectiveness of two strategies for distributing FIT (fecal immunochemical test) kits in a community-based colorectal cancer screening program targeting African Americans (AAs). The main questions this study aims to answer are: Does the on-site distribution of FIT kits result in higher return rates compared to direct mailing? Which distribution strategy (onsite vs. direct mailing) is a more cost-effective approach for increasing... Read More
Gender:
All
Ages:
Between 45 years and 75 years
Trial Updated:
10/03/2023
Locations: Department of Motor Vehicles (DMV), Omaha, Nebraska +1 locations
Conditions: Colorectal Cancer, Prevention
Hand-Arm Bimanual Intensive Therapy in Virtual Reality Versus Standard Hand-Arm Bimanual Intensive Therapy
Recruiting
The goal of this intervention study is- 1. To determine if a camp that solely uses VR software based on HABIT (HABIT-VR) still improves the motor planning and execution deficits in children with hemiplegic cerebral palsy (HCP) and 2. To determine if HABIT-VR improves bimanual coordination and affected hand function in children with HCP at least as well as a standard HABIT. Children with motor planning and execution deficits will receive 40 hours of either HABIT-VR or standard HABIT (4 hours per... Read More
Gender:
All
Ages:
Between 6 years and 16 years
Trial Updated:
10/02/2023
Locations: University of Nebraska Medical Center, Munroe-Meyer Institute, Omaha, Nebraska
Conditions: Hemiplegic Cerebral Palsy
Exoskeleton Variability Optimization
Recruiting
The investigators will evaluate a potentially faster and more clinically feasible method to optimize exoskeletons in pilot tests in healthy in preparation for patients with peripheral artery disease.
Gender:
All
Ages:
Between 19 years and 85 years
Trial Updated:
09/29/2023
Locations: University of Nebraska Omaha, Omaha, Nebraska
Conditions: Peripheral Arterial Disease
The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF
Recruiting
This study is to assess the efficacy of intraoperative intravenous nonsteroidal anti-inflammatory drug (ketorolac) versus intravenous (dexamethosone) administration on dysphagia and dysphonia after ACDF.
Gender:
All
Ages:
19 years and above
Trial Updated:
09/29/2023
Locations: University of Nebraska Medical Center, Lauritzen Outpatient Center, Omaha, Nebraska
Conditions: Dysphagia, Dysphonia
Family Connections: Cultural Adaptation and Feasibility Testing for Rural Latino Communities
Recruiting
Addressing childhood obesity risk factors like home environment, parental roles, excess weight, physical activity, and healthy eating among Latinos/Hispanic (L/H) families living in rural communities is an important priority. This study proposes to use cultural adaptation and implementation science frameworks to evaluate the feasibility of delivering a culturally appropriate family-based childhood obesity (FBCO) program via an automated telephone system (IVR) to L/H families living in rural Nebr... Read More
Gender:
All
Ages:
Between 6 years and 12 years
Trial Updated:
09/29/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Childhood Obesity
Coagulopathy of Immunodermatologic Diseases
Recruiting
This study will examine the coagulation and fibrinolysis profiles of those with autoimmune skin diseases. Blood samples will be collected from participants with active/poorly controlled immune-mediated skin diseases and mild/latent/well-controlled immune-mediated skin diseases. A one-time sample from 15 general dermatology outpatients who do not have a known or suspected diagnosis of bullous diseases, immune-mediated dermatologic condition, or cutaneous malignancy will also be collected to serve... Read More
Gender:
All
Ages:
19 years and above
Trial Updated:
09/29/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Autoimmune Bullous Dermatosis
Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab
Recruiting
This study is designed to determine if combining consolidative radiation therapy (RT) using a hypofractionated regimen (hfRT) (2 fractions) for boosting the residual primary lung cancer with adjuvant anti-PD-L1 therapy concurrently is safe and will provide better tumor control locoregionally and distantly than either modality alone.
Gender:
All
Ages:
19 years and above
Trial Updated:
09/29/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Lung Cancer, Carcinoma, Non-Small Cell Lung
The Loneliness Epidemic Tailoring Interventions to Reduce Loneliness and Pain
Recruiting
Building upon existing evidence on loneliness and pain research, conversational voice assistant (CVA)technology and personalized persuasion, we have assembled an interdisciplinary and inter-institutional team of researchers to conduct a 12-week randomized control pilot with older adults that live alone and self-report pain. Participants will interact with a standard or a personally enhanced loneliness routine delivered through a CVA. We will explore intervention feasibility and examine the effic... Read More
Gender:
All
Ages:
60 years and above
Trial Updated:
09/29/2023
Locations: Trinity Courtyard, Omaha, Nebraska +1 locations
Conditions: Pain, Chronic, Loneliness
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Recruiting
Cancer and treatment-related cognitive changes hinder resumption of normal routine and roles and worsen quality of life. Older adults undergoing hematopoietic cell transplantation (HCT) are at high-risk for cognitive impairment. Physical activity improves cognitive function in older adults and survivors of other cancers. We hypothesize that increasing physical activity can also improve cognitive function in this vulnerable population. The objective of this research is to adapt and test an eviden... Read More
Gender:
All
Ages:
60 years and above
Trial Updated:
09/29/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Leukemia, Lymphoma, Multiple Myeloma, MDS, Myeloproliferative Neoplasm
FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer
Recruiting
Purpose: To determine the feasibility and safety of combining digoxin as a modulator of the hypoxia pathway in combination with FOLinic acid, 5-Fluorouracil, IRINotecan and OXaliplatin (FOLFIRINOX) in patients with resectable pancreatic cancer.
Gender:
All
Ages:
19 years and above
Trial Updated:
09/29/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Pancreas Cancer, Adenocarcinoma of the Pancreas
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
Recruiting
The goal of this clinical trial is to learn about treatment for people with B-cell lymphoma that did not respond to treatment or that has gotten worse after treatment. The aim of this trial is to answer the following questions: If it is realistic to give people radiation treatment before they receive a chimeric antigen receptor (CAR) T-cell treatment for their cancer If it is safe to give people radiation treatment before they receive a CAR T-cell treatment for their cancer
Gender:
All
Ages:
19 years and above
Trial Updated:
09/28/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma, Mediastinal Large B-cell Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma
Protective Assets Reinforced With Integrated Care and TechnologY (PARITY) Feasibility Trial
Recruiting
This study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black women. PARITY is a program that provides community-based doula support, community resources, and a mobile technology platform that reinforces individual strengths (referred to as protective assets) throug... Read More
Gender:
Female
Ages:
Between 19 years and 51 years
Trial Updated:
09/28/2023
Locations: University of Nebraska Medical Center, Omaha, Nebraska
Conditions: Maternal Health, Blood Pressure